Back to
STATE STREET CORP
ABCL20 quarters
Position history for
STATE STREET CORP's holdings in ABCELLERA BIOLOGICS INC
Yes. State Street holds 731,362 shares of ABCL (Abcellera Biologics), worth $5.7M, as of its Q2 2026 13F filing. It increased the position by 1,149 shares (+0.2%) from Q1 2026. State Street has held ABCL since Q3 2021, across 20 quarterly 13F filings.
Current Value
$5.7M
Current Shares
731,362
Total Value Change
+$3.2M
Total Shares Change
+604,894
Quarter-by-Quarter History
Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors